Saturday, November 14, 2026

Nikkei 225 Went Up By Over 5% In The Last 21 Sessions

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Nikkei 225 Went Up By Over 5% In The Last 21 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 5.64% for the last 21 sessions. At 21:08 EST on Thursday, 4 July, Nikkei 225 (N225) is $40,888.09.

About Nikkei 225's yearly highs and lows, it's 34.11% up from its 52-week low and 0.52% down from its 52-week high.

Volatility

Nikkei 225's last week, last month's, and last quarter's current intraday variation average was 0.83%, 0.30%, and 0.81%, respectively.

Nikkei 225's highest amplitude of average volatility was 0.83% (last week), 0.65% (last month), and 0.81% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to Zacks on Wednesday, 3 July, "Validating its fundamental strength, UBER was added to the much sought-after S&P 500 index in December last year. ", "With a portfolio of 500 leading companies that have approximately 80% coverage of the available market capitalization, the S&P 500 is widely regarded as the best single measure of large-cap U.S. equities."
  • According to Zacks on Wednesday, 3 July, "The tech-heavy Nasdaq Composite Index outperformed, rising 6%, while the S&P 500 and the Dow Jones gained 3.5% and 1.1%, respectively, last month.", "In fact, the S&P 500 topped the 5,500 level after hitting the 5,400 mark earlier in June. "
  • According to Zacks on Wednesday, 3 July, "We were mixed ahead of a slew of economic data - more about this below - but are now -20 points on the Dow, -7 on the S&P 500 and -33 points on the Nasdaq at this hour. "
  • According to Business Insider on Wednesday, 3 July, "As of 7.55 am ET, the Dow futures were up 29.00 points, the S&P 500 futures were declining 2.00 points and the Nasdaq 100 futures were sliding 14.50 points.", "The S&P 500 settled at 5,509.01, gaining 33.92 points or 0.62%, while the Nasdaq advanced 149.46 points or 0.84 percent, to 18,028.76."
  • According to FXStreet on Wednesday, 3 July, "The S&P 500 and the NASDAQ both witnessed new all-time highs in Wednesday's shortened session after the ADP Employment Change report showed fewer new jobs in the US economy than expected. "

More news about Nikkei 225 (N225).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com